Coronary Artery Disease Diagnosis: Tests and Procedures

Diagnosing coronary artery disease (CAD) involves risk assessment, non-invasive testing, and, when indicated, invasive angiography. Choice depends on pre-test probability, symptoms, and guidelines.

Non-Invasive Tests

TestWhat It AssessesBest For
Exercise Stress ECGIschemic ST changes, symptoms, exercise capacityIntermediate risk, interpretable ECG, able to exercise
Stress EchocardiographyWall motion abnormalities with stressIntermediate risk, uninterpretable ECG, valve disease
Myocardial Perfusion Imaging (MPI/SPECT/PET)Perfusion defects (ischemia/scar)Intermediate-high risk, unable to exercise (pharmacologic stress)
CT Coronary Angiography (CCTA)Coronary anatomy, stenosis, plaque (calcified/non-calc)Low-intermediate risk, rule-out CAD, anomalous coronaries
Coronary Artery Calcium (CAC) ScoreCalcified plaque burden (Agatston score)Asymptomatic risk stratification (40–75 yrs), statin decisions
Resting EchocardiogramWall motion, EF, valves, pericardiumBaseline, HF eval, not for ischemia detection

Invasive Test

  • Invasive Coronary Angiography (ICA): Gold standard for lumenography. Guidewire + catheter, contrast injection. Allows immediate PCI/stent. Indicated for high-risk ACS, high pre-test probability, failed medical therapy, equivocal non-invasive.

Blood-Based Biomarkers

  • Lipid Panel: LDL-C, HDL-C, TG, non-HDL, ApoB.
  • Hs-CRP: Inflammation; refines risk.
  • Lp(a): Genetic risk enhancer.
  • Troponin: Acute myocardial injury (not stable CAD).

Guideline-Based Pathway (Simplified)

  1. Assess symptoms + risk factors (ASCVD score).
  2. Low risk: CAC or reassurance.
  3. Intermediate: CCTA (preferred) or functional stress test.
  4. High risk / ACS: ICA.

Shared decision-making incorporates patient preferences, radiation exposure, and resource availability.

Cardiovascular Disease - Related Articles